Anti-Human Apo CII

CR12 is a polyclonal antibody targeting human Apolipoprotein C-II (APOC2), an 8.8 kDa lipoprotein-associated protein that serves as the obligate activator of lipoprotein lipase (LPL). Validated for ELISA, Western blot, and immunodiffusion in human plasma and lipoprotein fraction samples, CR12 supports research into triglyceride metabolism, familial hypertriglyceridemia, and APOC2 deficiency.